Russia’s Sputnik V coronavirus vaccine is a “good vaccine” and is likely to receive approval in the European Union at some point, said Thomas Martens, head of the Standing Committee on Vaccination (STIKO) at Germany’s Robert Koch Institute.
In an interview with the German regional daily Rheinische Post, Thomas Martens said that “Russian researchers are very experienced with vaccinations. The Sputnik V vaccine is cleverly invented.”
He also hinted that the approval of the first Russian vaccine against COVID-19 could help solve the problem of vaccine shortages in the European Union.
The question of when exactly the Russian vaccine will be approved in the European Union remains open. The European Medicines Agency (EMA) announced last week that it will begin an ongoing review of the Sputnik V vaccine. This procedure can speed up the process of its possible approval, BNR writes.
According to the EMA, this procedure will continue as long as there is sufficient evidence for the application for approval for the use of the Russian vaccine in the EU.
However, some European countries no longer wanted to wait that long. In Hungary, Slovakia and the Czech Republic, the Sputnik V vaccine has already been approved or national procedures are underway for its approval.
Earlier this week, however, the European Medicines Agency officially advised European countries not to use Sputnik V, comparing a similar move to Russian roulette.
According to the developers of the Russian vaccine, it has already been approved in 46 countries around the world. The researchers said the Russian vaccine was almost 92% effective against Covid-19, based on peer-reviewed late-published studies published last month in the medical journal The Lancet. Like the AstraZeneca vaccine, Sputnik V is a vector vaccine based on adenovirus.